Pharmacology and Toxicology

  1. In vitro efficacy of Artemisia extracts against SARS-CoV-2

    1. Chuanxiong Nie
    2. Jakob Trimpert
    3. Sooyeon Moon
    4. Rainer Haag
    5. Kerry Gilmore
    6. Benedikt B. Kaufer
    7. Peter H. Seeberger

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  2. Development of Remdesivir as a Dry Powder for Inhalation by Thin Film Freezing

    1. Sawittree Sahakijpijarn
    2. Chaeho Moon
    3. John J. Koleng
    4. Dale J. Christensen
    5. Robert O. Williams

    Reviewed by ScreenIT

    3 evaluationsAppears in 1 listLatest version Latest activity

  3. Induction of Exaggerated Cytokine Production in Human Peripheral Blood Mononuclear Cells by a Recombinant SARS-CoV-2 Spike Glycoprotein S1 and Its Inhibition by Dexamethasone

    1. Olumayokun A. Olajide
    2. Victoria U. Iwuanyanwu
    3. Izabela Lepiarz-Raba
    4. Alaa A. Al-Hindawi

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  4. Iota-carrageenan and Xylitol inhibit SARS-CoV-2 in cell culture

    1. Shruti Bansal
    2. Colleen B. Jonsson
    3. Shannon L. Taylor
    4. Juan Manuel Figueroa
    5. Andrea Vanesa Dugour
    6. Carlos Palacios
    7. Julio César Vega

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  5. KLF2 is a therapeutic target for COVID-19 induced endothelial dysfunction

    1. Suowen Xu
    2. Sihui Luo
    3. Xueying Zheng
    4. Jianping Weng

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  6. Phospholipidosis is a shared mechanism underlying the in vitro antiviral activity of many repurposed drugs against SARS-CoV-2

    1. Tia A. Tummino
    2. Veronica V. Rezelj
    3. Benoit Fischer
    4. Audrey Fischer
    5. Matthew J. O’Meara
    6. Blandine Monel
    7. Thomas Vallet
    8. Ziyang Zhang
    9. Assaf Alon
    10. Henry R. O’Donnell
    11. Jiankun Lyu
    12. Heiko Schadt
    13. Kris M White
    14. Nevan J. Krogan
    15. Laszlo Urban
    16. Kevan M. Shokat
    17. Andrew C. Kruse
    18. Adolfo García-Sastre
    19. Olivier Schwartz
    20. Francesca Moretti
    21. Marco Vignuzzi
    22. Francois Pognan
    23. Brian K. Shoichet

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  7. Human ACE2 peptide mimics block SARS-CoV-2 Pulmonary Cells Infection

    1. Philippe Karoyan
    2. Vincent Vieillard
    3. Estelle Odile
    4. Alexis Denis
    5. Amélie Guihot
    6. Charles-Edouard Luyt
    7. Luis Gómez-Morales
    8. Pascal Grondin
    9. Olivier Lequin

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  8. A repurposed drug screen identifies compounds that inhibit the binding of the COVID-19 spike protein to ACE2

    1. Kaleb B. Tsegay
    2. Christiana M. Adeyemi
    3. Edward P. Gniffke
    4. D. Noah Sather
    5. John K. Walker
    6. Stephen E. P. Smith

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  9. Triphosphates of the Two Components in DESCOVY and TRUVADA are Inhibitors of the SARS-CoV-2 Polymerase

    1. Steffen Jockusch
    2. Chuanjuan Tao
    3. Xiaoxu Li
    4. Thomas K. Anderson
    5. Minchen Chien
    6. Shiv Kumar
    7. James J. Russo
    8. Robert N. Kirchdoerfer
    9. Jingyue Ju

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity

  10. Discovery of SARS-CoV-2 papain-like protease inhibitors through a combination of high-throughput screening and FlipGFP-based reporter assay

    1. Zilei Xia
    2. Michael Dominic Sacco
    3. Chunlong Ma
    4. Julia Alma Townsend
    5. Naoya Kitamura
    6. Yanmei Hu
    7. Mandy Ba
    8. Tommy Szeto
    9. Xiujun Zhang
    10. Xiangzhi Meng
    11. Fushun Zhang
    12. Yan Xiang
    13. Michael Thomas Marty
    14. Yu Chen
    15. Jun Wang

    Reviewed by ScreenIT

    1 evaluationAppears in 1 listLatest version Latest activity
Previous Page 18 of 22 Next